Skip to content
Screener

Reported August 13, 2026 · After market close

EPS-$2.94

Next report

Nov 17, 2026 (in 2 months)

FAQ

When did Calidi Biotherapeutics report Q2 2026 earnings?
Calidi Biotherapeutics (CLDI) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Calidi Biotherapeutics's Q2 2026 revenue and EPS?
Calidi Biotherapeutics reported eps of $-2.94 for Q2 2026.
How did Calidi Biotherapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 47.7% from $-1.99.
Where can I find Calidi Biotherapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037840) and the 10-Q periodic report (0001493152-26-037847) directly on SEC EDGAR. The filing index links above go to sec.gov.